home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 28, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

Bio-options,Inc.

1400 W. Lambert Road Ste. A
Brea, 92821
United States of America, California

Phone: 714-485-0120
Fax: 877-447-4465
E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it

Description:

Bio-options provides human tissues and biological materials for molecular research, drug development and diagnostic testing. We offer frozen and formalin fixed parrafin embedded (FFPE) tissue specimens from our extensive biorepository of all major diseases with a focus on the common tumors. We also provide TMAs, PBMCs and molecular testing.  Bio-options specializes in custom tissue procurement including the delivery of fresh specimens collected in media and delivered to researchers within 24 hours after removal. Bio-options partners with hospitals, physicians and clinical laboratories to procure remnant surgical specimens, blood products and other biofluid collections. We have procurement programs at 13 hospitals, located in Southern California, Midwest and East Coast.  Bio-options operates IRB approved studies to provide remnant tissue samples, blood, bone marrow, synovial fluid and many other biofluids.

We provide biospecimens from the following disease states:

 

  • Cancer:  bladder, breast, cervix, colorectal, hepatobiliary (liver), kidney, leukemia, lung, lymphoma, ovary, pancreas, prostate, skin (melanoma), stomach, uterus
  • Autoimmune:  diabetes, inflammatory bowel disease, sarcoidosis, Sjogren's, systemic erythematosus lupus (SLE), thyroid
  • Cardiovascular disease
  • Infectious disease

 



Selected Categories:
Product Company   Service Company
Biopharma
- Research
Biotech
- Research
Diagnostics
- in vitro
- Medical
Pharmaceutical
- Research
Supplier
- Research
Contract
- Research

Last update of this entry: September 28, 2022

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.